Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Shields

Showing results (311-320 of 533) with videos related to

Pageof 54
Sort By:
Diabetes Care|January 21, 2022
Improvements in Awareness and Testing Have Led to a Threefold Increase Over 10 Years in the Identification of Monogenic Diabetes in the U.KLewis Pang, Kevin C Colclough, Maggie H Shepherd, et al.
Diabetologia|September 20, 2018
A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metforminMaggie H Shepherd, Beverley M Shields, Michelle Hudson, et al.
Diabetes Research and Clinical Practice|July 24, 2020
Predicting post one-year durability of glucose-lowering monotherapies in patients with newly-diagnosed type 2 diabetes mellitus - A MASTERMIND precision medicine approach (UKPDS 87)Olorunsola F Agbaje, Ruth L Coleman, Andrew T Hattersley, et al.
Methods in Enzymology|June 8, 2006
Use of retrovirus expression of interfering RNA to determine the contribution of activated K-Ras and ras effector expression to human tumor cell growthAntonio T Baines, Kian-Huat Lim, Janiel M Shields, et al.
The New England Journal of Medicine|January 31, 2019
Case 4-2019: An 18-Year-Old Man with Abdominal Pain and HematocheziaHelen M Shields, Fabian J Scheid, Theodore T Pierce, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 28, 2025
Glycated albumin and fructosamine do not improve accuracy of glycaemic control assessment in patients with conditions reported to affect HbA<sub>1c</sub> reliabilityAnxious J Niwaha, Priscilla A Balungi, Timothy J McDonald, et al.
Plos One|June 10, 2016
Individual and Household Level Risk Factors Associated with Malaria in Nchelenge District, a Region with Perennial Transmission: A Serial Cross-Sectional Study from 2012 to 2015Jessie Pinchoff, Mike Chaponda, Timothy M Shields, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 9, 2024
The impact of prolonged walking on fasting plasma glucose in type 2 diabetes: A randomised controlled crossover studyAnxious J Niwaha, Beverley M Shields, Lauren R Rodgers, et al.
Digestive Diseases and Sciences|September 13, 2006
Multilayered epithelium may be found in patients with Barrett's epithelium and dysplasia or adenocarcinomaMelissa P Upton, Norman S Nishioka, Bernard J Ransil, et al.
Diabetes Care|August 6, 2015
Markers of β-Cell Failure Predict Poor Glycemic Response to GLP-1 Receptor Agonist Therapy in Type 2 DiabetesAngus G Jones, Timothy J McDonald, Beverley M Shields, et al.
Pageof 54

Showing results (311-320 of 533) with videos related to

Sort By:
Pageof 54
Diabetes Care|January 21, 2022
Improvements in Awareness and Testing Have Led to a Threefold Increase Over 10 Years in the Identification of Monogenic Diabetes in the U.KLewis Pang, Kevin C Colclough, Maggie H Shepherd, et al.
Diabetologia|September 20, 2018
A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metforminMaggie H Shepherd, Beverley M Shields, Michelle Hudson, et al.
Diabetes Research and Clinical Practice|July 24, 2020
Predicting post one-year durability of glucose-lowering monotherapies in patients with newly-diagnosed type 2 diabetes mellitus - A MASTERMIND precision medicine approach (UKPDS 87)Olorunsola F Agbaje, Ruth L Coleman, Andrew T Hattersley, et al.
Methods in Enzymology|June 8, 2006
Use of retrovirus expression of interfering RNA to determine the contribution of activated K-Ras and ras effector expression to human tumor cell growthAntonio T Baines, Kian-Huat Lim, Janiel M Shields, et al.
The New England Journal of Medicine|January 31, 2019
Case 4-2019: An 18-Year-Old Man with Abdominal Pain and HematocheziaHelen M Shields, Fabian J Scheid, Theodore T Pierce, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 28, 2025
Glycated albumin and fructosamine do not improve accuracy of glycaemic control assessment in patients with conditions reported to affect HbA<sub>1c</sub> reliabilityAnxious J Niwaha, Priscilla A Balungi, Timothy J McDonald, et al.
Plos One|June 10, 2016
Individual and Household Level Risk Factors Associated with Malaria in Nchelenge District, a Region with Perennial Transmission: A Serial Cross-Sectional Study from 2012 to 2015Jessie Pinchoff, Mike Chaponda, Timothy M Shields, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 9, 2024
The impact of prolonged walking on fasting plasma glucose in type 2 diabetes: A randomised controlled crossover studyAnxious J Niwaha, Beverley M Shields, Lauren R Rodgers, et al.
Digestive Diseases and Sciences|September 13, 2006
Multilayered epithelium may be found in patients with Barrett's epithelium and dysplasia or adenocarcinomaMelissa P Upton, Norman S Nishioka, Bernard J Ransil, et al.
Diabetes Care|August 6, 2015
Markers of β-Cell Failure Predict Poor Glycemic Response to GLP-1 Receptor Agonist Therapy in Type 2 DiabetesAngus G Jones, Timothy J McDonald, Beverley M Shields, et al.
Pageof 54